Yahoo Finance•5 days ago
Rallybio Corporation is a clinical-stage biotechnology company offering programs for the prevention of Fetal and Neonatal Alloimmune Thrombocytopenia, a rare hematological disease that impacts fetuses and newborns. The company is also focused on developing therapies that address diseases of complement dysregulation, including Paroxysmal Nocturnal Hemoglobinuria, Generalized Myasthenia Gravis, and ophthalmic disorders. Rallybio Corporation was founded in 2018 and is headquartered in New Haven, CT.
What is Rallybio's quote symbol?
What is the 52 week high and low for Rallybio (NASDAQ: RLYB)?
How much is Rallybio stock worth today?
How much is Rallybio's stock price per share?
What is Rallybio's Market Cap?